{"id":"cromoglicate","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute nephropathy","Disease of liver","Hepatic failure","Kidney disease","Nasal polyp"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT00814073","NCT01841307","NCT05077917","NCT04333108","NCT00943397","NCT00745199","NCT06535087","NCT02566252","NCT02131038","NCT02664051","NCT03167216","NCT05076682","NCT01346852","NCT02371941","NCT07142291","NCT04846348","NCT04570644","NCT04428775","NCT06801626","NCT02547818","NCT04408664","NCT00777348","NCT01701843","NCT05449444","NCT01933464","NCT01175525","NCT03794076","NCT03202147","NCT01722812","NCT07419880","NCT02482324","NCT02478957"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Cromoglicate","companyId":"leo-pharma","ecosystem":[],"mechanism":{"target":"Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"LEO Pharma","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Cromoglicate","indications":{"approved":[{"name":"Allergic Keratoconjunctivitis","diseaseId":"allergic-keratoconjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic conjunctivitis","diseaseId":"allergic-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma","diseaseId":"asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma management","diseaseId":"asthma-management","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bronchospasm Prevention","diseaseId":"bronchospasm-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Giant papillary conjunctivitis","diseaseId":"giant-papillary-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Systemic mast cell disease","diseaseId":"systemic-mast-cell-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vernal Keratitis","diseaseId":"vernal-keratitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vernal conjunctivitis","diseaseId":"vernal-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vernal keratoconjunctivitis","diseaseId":"vernal-keratoconjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00814073","phase":"Phase 3","title":"Randomized, Placebo-controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib at 6 mg/kg/Day to Placebo in Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous M","status":"COMPLETED","sponsor":"AB Science","isPivotal":true,"enrollment":135,"indication":"Indolent Systemic Mastocytosis","completionDate":"2015-11"},{"nctId":"NCT01841307","phase":"Phase 1","title":"Development and Validation of Test for Gastro-esophageal Reflux and Aspiration","status":"TERMINATED","sponsor":"University of California, San Francisco","isPivotal":false,"enrollment":16,"indication":"Gastroesophageal Reflux, Respiratory Aspiration","completionDate":"2017-09"},{"nctId":"NCT05077917","phase":"Phase 3","title":"Cromolyn Sodium for Treatment of COVID-19 Pneumonia","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","isPivotal":true,"enrollment":22,"indication":"COVID-19 Pneumonia, COVID-19 Respiratory Infection","completionDate":"2024-05-23"},{"nctId":"NCT04333108","phase":"Phase 3","title":"Phase 3 Study to Compare Oral Masitinib to Placebo in Treatment of Patients With Smouldering or Indolent Severe Systemic Mastocytosis, Unresponsive to Optimal Symptomatic Treatment","status":"UNKNOWN","sponsor":"AB Science","isPivotal":true,"enrollment":140,"indication":"Indolent Systemic Mastocytosis","completionDate":"2025-06"},{"nctId":"NCT00943397","phase":"Phase 3","title":"A Multicenter, Open-Label, Controlled, Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma","status":"COMPLETED","sponsor":"Organon and Co","isPivotal":true,"enrollment":190,"indication":"Asthma","completionDate":"2001-11"},{"nctId":"NCT00745199","phase":"Phase 2","title":"Phase II Study of the Effect of Oral Cromolyn Sodium on Uremic Pruritus and Serum Tryptase Levels of Hemodialysed Patients","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","isPivotal":false,"enrollment":62,"indication":"End Stage Renal Disease, Pruritus","completionDate":"2009-06"},{"nctId":"NCT06535087","phase":"N/A","title":"The Impact of Airway Allergic Diseases on the Health-related Quality of Life of Children and Their Parents (Caregivers): A Prospective Controlled Study","status":"RECRUITING","sponsor":"Wenjing Zhou","isPivotal":false,"enrollment":600,"indication":"Pediatric Asthma, Rhinitis, Allergic","completionDate":"2027-05-31"},{"nctId":"NCT02566252","phase":"Phase 1","title":"A Randomized, Open-label, Crossover Study to Assess the Safety, Tolerability, and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects and the Effect of Pretreatment With Cromolyn Sodiu","status":"COMPLETED","sponsor":"Pulmotect, Inc.","isPivotal":false,"enrollment":16,"indication":"Healthy","completionDate":"2016-03"},{"nctId":"NCT02131038","phase":"N/A","title":"Non Interventional, Open Label Trial of Ectoine Containing Nasal Spray in Comparison With Cromoglycic Acid Containing Nasal Spray in Patients With Allergic Rhinitis","status":"COMPLETED","sponsor":"Bitop AG","isPivotal":false,"enrollment":50,"indication":"Allergic Rhinitis","completionDate":"2009-09"},{"nctId":"NCT02664051","phase":"Phase 4","title":"The Role of Mast Cells on Duodenal Permeability After Duodenal Acid Perfusion in Healthy Volunteers","status":"TERMINATED","sponsor":"Universitaire Ziekenhuizen KU Leuven","isPivotal":false,"enrollment":20,"indication":"Dyspepsia","completionDate":"2021-06-29"},{"nctId":"NCT03167216","phase":"EARLY/Phase 1","title":"Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction","status":"COMPLETED","sponsor":"Northwestern University","isPivotal":false,"enrollment":20,"indication":"Chronic Prostatitis With Chronic Pelvic Pain Syndrome","completionDate":"2022-06-30"},{"nctId":"NCT05076682","phase":"Phase 2","title":"Reverse Triple Negative Immune Resistant Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","isPivotal":false,"enrollment":80,"indication":"Triple-negative Breast Cancer","completionDate":"2027-03-31"},{"nctId":"NCT01346852","phase":"N/A","title":"Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","isPivotal":false,"enrollment":101437,"indication":"Asthma","completionDate":"2010-04"},{"nctId":"NCT02371941","phase":"Phase 4","title":"A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"University of Tennessee","isPivotal":false,"enrollment":16,"indication":"Eosinophilic Esophagitis","completionDate":"2017-12"},{"nctId":"NCT07142291","phase":"Phase 2","title":"A Phase IIB Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Study to Evaluate the Effects of PHENOGENE-1A (Cromolyn) as an Adjuvant Treatment in Subjects With Mild to Moderate Amyotrophic Lat","status":"RECRUITING","sponsor":"PhenoNet, Inc.","isPivotal":false,"enrollment":105,"indication":"Amyotrophic Lateral Sclerosis (ALS)","completionDate":"2028-03"},{"nctId":"NCT04846348","phase":"Phase 2","title":"An Open-Label Pilot Study to Evaluate the Effectiveness and Tolerability of a Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis","status":"TERMINATED","sponsor":"Joseph Butterfield","isPivotal":false,"enrollment":1,"indication":"Cutaneous Mastocytoses","completionDate":"2021-09-10"},{"nctId":"NCT04570644","phase":"Phase 1","title":"A Phase I/II Randomized, Open-Labeled Study to Evaluate Pharmacokinetic and Pharmacodynamic Effects and Safety of ALZT-OP1 in Subjects With Alzheimer's Disease and Normal Healthy Volunteers","status":"COMPLETED","sponsor":"AZTherapies, Inc.","isPivotal":false,"enrollment":56,"indication":"Healthy Volunteers, Alzheimer Disease","completionDate":"2021-01-18"},{"nctId":"NCT04428775","phase":"Phase 2","title":"A Phase IIa, Randomized, Open-label, Multi-Center, Multi-Dose Study to Evaluate the Effects of ALZT-OP1a in Subjects With Mild-Moderate Stage Amyotrophic Lateral Sclerosis (ALS)","status":"TERMINATED","sponsor":"AZTherapies, Inc.","isPivotal":false,"enrollment":12,"indication":"Amyotrophic Lateral Sclerosis","completionDate":"2021-10-01"},{"nctId":"NCT06801626","phase":"Phase 3","title":"Novel Strategies for Reducing Burn Scar Itch","status":"RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","isPivotal":true,"enrollment":44,"indication":"Burn Scar, Itch Scarring","completionDate":"2027-11-01"},{"nctId":"NCT02547818","phase":"Phase 3","title":"A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease","status":"COMPLETED","sponsor":"AZTherapies, Inc.","isPivotal":true,"enrollment":620,"indication":"Alzheimer's Disease","completionDate":"2020-11-18"},{"nctId":"NCT04408664","phase":"Phase 3","title":"WP3-Influence of Cromones on EVH-test in Young (Elite) Athletes Who Tested Positive for EIB (=Exercise Induced Bronchoconstriction)","status":"TERMINATED","sponsor":"Universitaire Ziekenhuizen KU Leuven","isPivotal":true,"enrollment":8,"indication":"Exercise-Induced Bronchoconstriction","completionDate":"2023-08-01"},{"nctId":"NCT00777348","phase":"Phase 2","title":"Clinical Trial to Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol in Comparison to the Single Components and Placebo in Adults With Exercise Induced","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","isPivotal":false,"enrollment":62,"indication":"Asthma, Exercise-Induced","completionDate":"2008-10"},{"nctId":"NCT01701843","phase":"Phase 2","title":"A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis","status":"TERMINATED","sponsor":"LEO Pharma","isPivotal":false,"enrollment":7,"indication":"Mastocytosis","completionDate":"2013-02"},{"nctId":"NCT05449444","phase":"Phase 2","title":"A 24-week, Multicenter, Randomized, Double Blind, Placebo-controlled, Dose-range Finding Phase II Study to Compare Efficacy and Safety of Oral Masitinib to Placebo in Treatment of Patients With Severe","status":"UNKNOWN","sponsor":"AB Science","isPivotal":false,"enrollment":72,"indication":"Mast Cell Activation Syndrome","completionDate":"2024-12-31"},{"nctId":"NCT01933464","phase":"Phase 1","title":"An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema","status":"COMPLETED","sponsor":"University of California, San Diego","isPivotal":false,"enrollment":10,"indication":"Papulopustular Rosacea","completionDate":"2014-04"},{"nctId":"NCT01175525","phase":"Phase 3","title":"","status":"UNKNOWN","sponsor":"Wolfson Medical Center","isPivotal":true,"enrollment":0,"indication":"Acute Stroke","completionDate":""},{"nctId":"NCT03794076","phase":"Phase 1","title":"Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia","status":"RECRUITING","sponsor":"Vishwajit Nimgaonkar, MD PhD","isPivotal":false,"enrollment":160,"indication":"Schizophrenia, Schizo Affective Disorder","completionDate":"2028-06"},{"nctId":"NCT03202147","phase":"Phase 2","title":"A Phase II Safety and Efficacy Study of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)","status":"WITHDRAWN","sponsor":"AZTherapies, Inc.","isPivotal":false,"enrollment":0,"indication":"Ischemic Stroke, Post-stroke Cognitive Impairment","completionDate":"2024-12"},{"nctId":"NCT01722812","phase":"Phase 2","title":"An Exploratory Study Evaluating the Efficacy of Cromoglicate Cream Compared to Cream Vehicle in the Treatment of Itch in Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","isPivotal":false,"enrollment":30,"indication":"Psoriasis","completionDate":"2013-05"},{"nctId":"NCT07419880","phase":"Phase 2","title":"RECLAIM: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","isPivotal":false,"enrollment":46,"indication":"Triple -Negative Breast Cancer","completionDate":"2027-04-30"},{"nctId":"NCT02482324","phase":"Phase 1","title":"A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers","status":"COMPLETED","sponsor":"AZTherapies, Inc.","isPivotal":false,"enrollment":26,"indication":"Healthy Volunteers","completionDate":"2015-07"},{"nctId":"NCT02478957","phase":"Phase 2","title":"Randomized, Double-blind, Placebo-controlled, Crossover Design, Efficacy and Safety Study With PA101 in Patients With Indolent Systemic Mastocytosis","status":"COMPLETED","sponsor":"Patara Pharma","isPivotal":false,"enrollment":41,"indication":"Mastocytosis, Systemic Mastocytosis","completionDate":"2016-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Respiratory"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}